Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
30 October 2018 | Story Rulanzen Martin | Photo Peet van Aardt
iCAN contributes to a decolonised curriculum
Some of the student writers who contributed to the anthology that tells their stories in Sesotho, isiXhosa, isiZulu, English and Afrikaans.

How do you transform the higher education curriculum? You involve the exact people the curriculum is intended for. The book, Initiative for Creative African Narratives (iCAN,) illustrates how decolonisation can be achieved through literature   for students by students.

iCAN is an initiative by the Centre for Teaching and Learning (CTL) at the University of the Free State (UFS) to mentor students in creative and narrative writing. Under the mentorship of Dr Peet van Aardt, project coordinator, and Ace Moloi, author and UFS alumnus, iCAN Volume 1 was recently launched with 47 short stories written by UFS students. 

“The project is a response from the centre for the ever-increasing need for decolonised curricula, steeped in the local cultural perspective of ubuntu,” said Dr Van Aardt.

“This book is an example for how decolonisation can be implemented,” said Prof Francois Stydrom, Senior Director of CTL. The overall aim of the iCAN project is to have the content that materialised from it to be included in the curriculum of first-year students at UFS in the near future.

Book provides multiple voices

Starting in May 2018, CTL presented a series of creative writing workshops on all three of the UFS campuses. “It’s a medium that allows a diverse range of students to express their views and develop their voices as writers,” said Prof Strydom.  

It is a form of empowerment, to pass the baton to students to improve the UFS curriculum by writing and publishing their own stories, thereby contributing to larger bodies of knowledge through their lived experiences.

“I believe we as a university need to enable students so that they move away from just being users to becoming contributors to the curriculum,” Dr van Aardt concluded. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept